We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current CTSO market cap is 37.59M. The company's latest EPS is USD -0.6415 and P/E is -1.26.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 8.11M | 9.39M | 9.45M | 9.39M | 8.81M |
| Operating Income | -9.02M | -6.72M | -7.89M | -6.59M | -7.42M |
| Net Income | -12.2M | -767k | -7.33M | -6.15M | -9.19M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 24.95M | 41.01M | 43.17M | 34.69M | 36.35M |
| Operating Income | -18.97M | -10.37M | -22.74M | -31.52M | -31.21M |
| Net Income | -19.27M | -7.84M | -24.56M | -32.81M | -28.51M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 62.27M | 63.23M | 57.46M | 52.44M | 47.58M |
| Total Liabilities | 23.13M | 27.86M | 28.51M | 28.35M | 29.06M |
| Total Equity | 39.14M | 35.38M | 28.96M | 24.09M | 18.51M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 27.38M | 89.95M | 89.52M | 63.23M | 53.26M |
| Total Liabilities | 23.97M | 10.74M | 26.94M | 27.86M | 29.99M |
| Total Equity | 3.42M | 79.22M | 62.58M | 35.38M | 23.28M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -22.89M | -28.23M | -3.11M | -10.04M | -15.25M |
| Investing | -6.25M | -6.46M | -683k | -542k | -800k |
| Financing | -40k | 4.96M | 685k | 1.62M | 2.26M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -17.93M | -5.61M | -14.01M | -28.23M | -21.66M |
| Investing | -1.52M | -1.68M | -4.28M | -6.46M | -936k |
| Financing | 9.35M | 66.35M | 715k | 4.96M | 14.47M |
| Market Cap | 37.59M |
| Price to Earnings Ratio | -1.26 |
| Price to Sales Ratio | 0.99 |
| Price to Cash Ratio | 2.55 |
| Price to Book Ratio | 1.55 |
| Dividend Yield | - |
| Shares Outstanding | 44.44M |
| Average Volume (1 week) | 105.81k |
| Average Volume (1 Month) | 93.52k |
| 52 Week Change | -65.90% |
| 52 Week High | 4.29 |
| 52 Week Low | 0.782 |
| Spread (Intraday) | 0.06 (7.3%) |
| Company Name | CytoSorbents Corporation |
| Address |
874 walker rd ste c dover, delaware 19904 |
| Website | https://www.cytosorbents.com |
| Industry | surgical,med instr,apparatus (3841) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
